欧林生物：副总经理、财务负责人谭勇减持约13万股，减持计划实施完毕

Company Summary - Olin Bio announced on November 3 that from September 29, 2025, to October 31, 2025, the company's Vice President and Chief Financial Officer, Mr. Tan Yong, reduced his shareholding by approximately 130,000 shares, accounting for 0.0317% of the company's total share capital. The reduction plan has been completed [1]